tiprankstipranks
Relay Therapeutics (RLAY)
NASDAQ:RLAY
US Market

Relay Therapeutics (RLAY) Similar Stocks

Compare
429 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Relay Therapeutics
$4.09
$684.60M
-61.31%
7 Buy
0 Hold
0 Sell
Strong Buy
Exelixis
$35.09
$9.57B
19.79
69.35%
12 Buy
8 Hold
0 Sell
Moderate Buy
Incyte
$71.38
$13.79B
258.70
18.32%
6 Buy
8 Hold
1 Sell
Moderate Buy
Vertex Pharmaceuticals
$480.33
$118.67B
14.47%
14 Buy
12 Hold
1 Sell
Moderate Buy
Fate Therapeutics
$1.54
$174.26M
-77.54%
3 Buy
2 Hold
0 Sell
Moderate Buy
Blueprint Medicines
$94.35
$5.91B
8.13%
11 Buy
4 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
$ Change
% Change
RLAY
Relay Therapeutics
4.09
-6.48
-61.31%
EXEL
Exelixis
35.09
14.38
69.44%
INCY
Incyte
71.38
10.47
17.19%
VRTX
Vertex Pharmaceuticals
480.33
53.55
12.55%
FATE
Fate Therapeutics
1.54
-5.34
-77.62%
BPMC
Blueprint Medicines
94.35
8.35
9.71%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis